LexDanaLexDanabeta
Inventor

YONGQI MU

Inventor
US

Overview

3→
Patents
2022–2026
Patent span
Chemistry
Primary field (CPC C)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
C07CAcyclic or carbocyclic compounds11%
C08FMacromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds11%
PatentTitleYear
12,522,682Synthesis of methyl 2-fluoroacrylate202612,258,316Biphenyl compounds useful as muscarinic receptor antagonists202511,247,969Biphenyl compounds useful as muscarinic receptor antagonists2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2025Patents assigned to THERAVANCE BIOPHARMA R&D IP LLC (2)· patent assignee history
2022–2026Based in US· patent location history
2026Patents assigned to VIFOR INT LTD (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
THERAVANCE BIOPHARMA R&D IP LLC22022–2025
VIFOR INT LTD12026
Locations
LocationPatentsSpan
US32022–2026